“Artificial Intelligence -Driven 3D Printing in Pharma: Innovations and Future Directions”

Abstract

The technology of three-dimensional printing which was applied in a new way to a medication production facility is an extremely impactful process that is now making things like drug delivery and the medicine became personalized a reality on a scale that has never existed before. The primary objective is to produce through a low-cost method the personalized products that are very complex and created on-demand. This review will provide an analysis of many different 3D printing technologies, including the Powder Bed Fusion (PBF) methods such as the Selective Laser Sintering (SLS) and the Direct Metal Laser Sintering (DMLS), which give the ability to produce the drug delivery systems that are accurate and have the controlled release profiles. Techniques like Nozzle-based and Fused Deposition Modeling (FDM) makes it possible to extend the versatility of 3D printing to create individual dosage forms and the implants thus, tailor treatment for the patient. The synergy of artificial intelligence and 3D printing robustly enhances the pharmaceutical industry, as a well as a creation of a newfound era of innovation and precision is brought into the medical world. The text you read educates people on the ways that the combination of AI 3D printing and pharma can advance. Major steps comprise personalized pharmaceuticals and drug delivery systems, which are developed for unique patient needs, drug formulation, which has been saved by rapid prototyping, and one of the main achievements was bioprinting the tissues for regeneration and regenerative medicine. AI is the end-point of 3D printing interactions as long as it speeds up the interface and makes the process more accurate and efficient. The possible patterns denote the forward development of AI algorithms, the inevitable of the availability digital health tech, as well as the necessity for government regulation development. Regard to the future, the existing research is focused on these technologies that are to be bettered/optimized in order to give a chance for hi-tech therapeutic treatments through direct pharmaceutical solutions.